Patients with cancer are at a significantly increased risk of experiencing a venous thromboembolism (VTE). VTE is defined by a blood clot in the leg or lower extremity (deep vein thrombosis) or a blood clot in the lung (pulmonary embolism) and is a leading cause of condition of being diseased and death among cancer patients. The goal of the study is to gather information how often venous thromboembolism (VTE) occurs in prostate cancer patients in Sweden and how this condition is treated with blood thinners.
Study Type
OBSERVATIONAL
Enrollment
97,765
Follow clinical administration
Follow clinical administration
Follow clinical administration
Many Locations
Multiple Locations, Sweden
Subject's socio-demographic at the date of an incident PCa diagnosis
Among men with PCa
Time frame: Retrospective analysis between 2007 and 2016
Subject's clinical characteristics at the date of an incident PCa diagnosis
Among men with PCa
Time frame: Retrospective analysis between 2007 and 2016
Incidence rate of cancer-related VTE
Among men with PCa
Time frame: Retrospective analysis between 2007 and 2016
Cancer therapies in PCa at the initial time after diagnosis
Among men with PCa
Time frame: Retrospective analysis between 2007 and 2016
Choice of drug
Among men with PCa and a first cancer-related VTE event； To characterize the long-term anticoagulation treatment
Time frame: Retrospective analysis between 2007 and 2016
Duration of treatment
Among men with PCa and a first cancer-related VTE event； To characterize the long-term anticoagulation treatment
Time frame: Retrospective analysis between 2007 and 2016
Occurrence of recurrent VTE events
Among men with PCa and a first cancer-related VTE event； By long-term anticoagulation treatment (LMWH (Low molecular weight heparin), VKA (Vitamin K anticoagulants) or NOAC (Non-vitamin K oral anticoagulation)) and its estimated duration (up 3 months, 3-6 months, more than 6 months)
Time frame: Retrospective analysis between 2007 and 2016
Time between a first cancer-related and a recurrent VTE event
Among men with PCa and a first cancer-related VTE event
Time frame: Retrospective analysis between 2007 and 2016
Incidence rates of post-VTE bleeding events leading to hospitalization, and mortality by anticoagulation treatment
Among men with PCa and a first cancer-related VTE event
Time frame: Retrospective analysis between 2007 and 2016
Subject's socio-demographic at the time of inclusion into the database
Among PCa-free men from the general population
Time frame: Retrospective analysis between 2007 and 2016
Subject's clinical characteristics at the time of inclusion into the database
Among PCa-free men from the general population
Time frame: Retrospective analysis between 2007 and 2016
Incidence rate of VTE events
Among PCa-free men from the general population
Time frame: Retrospective analysis between 2007 and 2016
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.